Swap medications: If your body does not tolerate semaglutide well, there are other GLP-1 drugs that your doctor can consider, including tirzepatide (Zepbound) The key is to communicate with your healthcare provider
There is, however, a limited exception for medical necessity
Experts caution against using experimental peptides for #LongCOVID
Lo studio AWARD-7 [55] ha reclutato e randomizzato 577 pazienti diabetici con CKD stadi G3 e G4 in 3 bracci: 1) dulaglutide 1,5 mg settimanali, 2) dulaglutide 0,75 mg settimanali e 3) insulina glargine, tutti in associazione con insulina lispro
Without clear information, it is easy to confuse something that is being studied with something that has actually been approved
This pattern reflects the underlying biology: the medication addresses the symptom (excess appetite) but not the permanent genetic or metabolic factors driving weight gain vulnerability